A detailed history of Glass Jacobson Investment Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Glass Jacobson Investment Advisors LLC holds 92 shares of AZN stock, worth $7,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92
Previous 92 -0.0%
Holding current value
$7,127
Previous $6.23 Million 15.13%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$61.03 - $69.57 $12,816 - $14,609
-210 Reduced 69.54%
92 $6.23 Million
Q4 2023

Jan 22, 2024

SELL
$61.89 - $69.28 $495 - $554
-8 Reduced 2.58%
302 $20.3 Million
Q3 2023

Nov 07, 2023

BUY
$64.85 - $71.7 $13,423 - $14,841
207 Added 200.97%
310 $21 Million
Q2 2023

Jul 25, 2023

SELL
$69.91 - $75.81 $699 - $758
-10 Reduced 8.85%
103 $7.37 Million
Q4 2022

Feb 06, 2023

BUY
$54.21 - $70.44 $6,125 - $7,959
113 New
113 $7.66 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Glass Jacobson Investment Advisors LLC Portfolio

Follow Glass Jacobson Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glass Jacobson Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glass Jacobson Investment Advisors LLC with notifications on news.